The impact of metformin treatment on adiponectin and resistin levels in women with polycystic ovary syndrome: a prospective clinical study.
Women with polycystic ovary syndrome (PCOS) are often characterized by adiposity and insulin resistance (IR). Recent studies in patients with obesity and diabetes mellitus type 2 (DMt2) indicate that adiponectin and resistin may play a role in the pathophysiology of IR. The aim of this study was to identify a possible correlation between the plasma levels of adiponectin and resistin and IR in patients with PCOS. Thirty-one women of reproductive age were enrolled in this prospective study after being diagnosed with PCOS and IR according to Rotterdam and American Diabetes Association (ADA) criteria, respectively. Every patient was treated with a daily dose of 1275 mg metformin for 6 months. Adiponectin, resistin, and the primary hormonal and metabolic parameters of the syndrome were evaluated at entry and endpoint of treatment. Adiponectin plasma levels were reduced after metformin treatment, but resistin levels were not significantly affected. Our study suggests that circulating levels of adiponectin should be evaluated with skepticism in patients with PCOS. The adipokine's role in the manifestation of IR in PCOS remains unclear and needs further investigation.
3rd Department of Obstetrics and Gynecology, Athens University Medical School, Attikon University Hospital , Athens , Greece and.
G
G
Basios
E
E
Trakakis
Ch
Ch
Chrelias
P
P
Panagopoulos
V
V
Vaggopoulos
P
P
Skarpas
D
D
Kassanos
G
G
Dimitriadis
E
E
Hatziagelaki
D052242:Adiponectin / Q000097:blood*; D000328:Adult; D015992:Body Mass Index; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000188:drug therapy* / Q000378:metabolism; D052243:Resistin / Q000097:blood*; D055815:Young Adult
C499918:ADIPOQ protein, human; D052242:Adiponectin; D007328:Insulin; C499624:RETN protein, human; D052243:Resistin; D008687:Metformin
Adipose tissue; adiponectin; insulin resistance; metformin; resistin